PharmacyCodes



M.V.I. Pediatric en es it fr

M.V.I. Pediatric Brand names, M.V.I. Pediatric Analogs

M.V.I. Pediatric Brand Names Mixture

  • No information avaliable

M.V.I. Pediatric Chemical_Formula

C31H46O2

M.V.I. Pediatric RX_link

http://www.rxlist.com/cgi/generic3/phytonadione.htm

M.V.I. Pediatric fda sheet

M.V.I. Pediatric msds (material safety sheet)

M.V.I. Pediatric Synthesis Reference

No information avaliable

M.V.I. Pediatric Molecular Weight

450.696 g/mol

M.V.I. Pediatric Melting Point

-20 oC

M.V.I. Pediatric H2O Solubility

Insoluble in water

M.V.I. Pediatric State

Liquid

M.V.I. Pediatric LogP

8.841

M.V.I. Pediatric Dosage Forms

Liquid

M.V.I. Pediatric Indication

For the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemia

M.V.I. Pediatric Pharmacology

Phytonadione is a vitamin, indicated in the treatment of coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. Phytonadione aqueous colloidal solution of vitamin K1 for parenteral injection, possesses the same type and degree of activity as does naturally-occurring vitamin K, which is necessary for the production via the liver of active prothrombin (factor II), proconvertin (factor VII), plasma thromboplastin component (factor IX), and Stuart factor (factor X).

M.V.I. Pediatric Absorption

Oral phytonadione is adequately absorbed from the gastrointestinal tract only if bile salts are present. After absorption, phytonadione is initially concentrated in the liver, but the concentration declines rapidly. Very little vitamin K accumulates in tissues.

M.V.I. Pediatric side effects and Toxicity

No information avaliable

M.V.I. Pediatric Patient Information

No information avaliable

M.V.I. Pediatric Organisms Affected

Humans and other mammals